4.6 Article

LINC00365 functions as a tumor suppressor by inhibiting HIF-1?-mediated glucose metabolism reprogramming in breast cancer

期刊

EXPERIMENTAL CELL RESEARCH
卷 425, 期 1, 页码 -

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2023.113514

关键词

LINC00365; HIF-1?; Glycolysis; Breast cancer

向作者/读者索取更多资源

Long non-coding RNAs (lncRNAs) are involved in regulating physiological processes and implicated in various diseases, including cancer. In breast cancer (BC), the role of lncRNAs has been extensively studied. This research focuses on the LINC00365/HIF-1 alpha axis and its impact on tumor growth through glycolysis. The findings suggest that targeting LINC00365 could reverse the glucose metabolism pattern in BC and effectively inhibit BC survival.
Long non-coding RNAs (lncRNAs) play an important role in regulating several physiological processes and have been implicated in several pathologies including cancer. LncRNAs have been found to regulate key cellular pathways involved in cancer development, and their aberrant expression plays critical roles in the onset or progression of disease. The role of lncRNAs in breast cancer (BC) has become a hot topic of research in recent years. We previously showed that LINC00365 inhibits BC survival. In the current study, based on the important role of energy metabolism and HIF-1 alpha for tumor cell proliferation, we investigated the role and mechanism of the LINC00365/HIF-1 alpha axis in affecting tumor growth through glycolysis using the breast cancer cell lines MCF-7 and HCC-1937. We found that LINC00365 inhibited BC cell proliferation. Furthermore, LINC00365 over -expression suppressed aerobic glycolysis in BC cells. RNA-sequencing identified hypoxia-inducible factor-1 alpha (HIF-1 alpha), which has been linked with glycolysis and upregulates glycolysis-related genes, as a potential target gene of LINC00365. Accordingly, we found that LINC00365 overexpression resulted in decreased expression of key glycolytic enzymes such as downstream hexokinase 2 (HK2), recombinant pyruvate kinase isozymes M2 (PKM2) and lactate dehydrogenase A (LDHA). Our results suggest that targeting LINC00365 may reverse the glucose metabolism pattern of BC and effectively inhibit BC survival both in vitro and in vivo.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据